DBS and Neuro-therapies: Effective, Evolving Solutions

Johan P. van der Meer^*
*Correspondence: Johan P. van der Meer, Department of Clinical Neurology, University of Amsterdam, Amsterdam, Netherlands, Email:

Introduction

Functional neurosurgery offers a range of advanced therapeutic options for complex neurological and psychiatric conditions. This field is continuously evolving, demonstrating remarkable efficacy in improving patient outcomes. One area of significant focus is Deep Brain Stimulation (DBS), which has proven to be a durable and effective treatment across various disorders. For instance, a comprehensive study has highlighted the long-term effectiveness of globus pallidus internus (GPi) DBS for Parkinson's disease, showing sustained improvements in motor symptoms and overall quality of life [1].

Optimal long-term outcomes from GPi DBS depend heavily on careful patient selection and expert surgical technique.In parallel, Anterior Nucleus of Thalamus (ANT) DBS has emerged as a viable alternative for individuals with drug-resistant epilepsy. A systematic review and meta-analysis confirms that ANT DBS can significantly reduce seizure frequency over extended periods [2].

This approach also demonstrates a generally manageable safety profile, playing a vital role in enhancing the quality of life for patients suffering from severe epilepsy.Beyond DBS, non-invasive and minimally invasive techniques are also gaining prominence. Focused ultrasound thalamotomy, for example, is an effective treatment for essential tremor. This non-invasive ablative technique provides immediate and significant tremor suppression, directly improving motor function and the quality of life for affected patients [3].

The procedure's safety profile, typically involving transient side effects, positions it as a valuable alternative to traditional surgical methods.Similarly, for chronic pain management, spinal cord stimulation (SCS) has shown substantial benefits. A comprehensive systematic review and meta-analysis indicates that SCS offers significant pain relief and functional improvement for patients who have not responded to conventional therapies [4].

Successful long-term pain management with SCS relies on meticulous patient selection and a robust multidisciplinary care approach.The application of DBS extends to psychiatric disorders, particularly severe, treatment-resistant obsessive-compulsive disorder (OCD). A detailed systematic review and meta-analysis of individual patient data confirmed significant symptom reduction and improved functional outcomes for a substantial number of patients [5].

DBS stands as a critical therapeutic option when other treatments fail, providing sustained benefits and underscoring the necessity for specialized centers and precise patient selection.Stereotactic radiosurgery (SRS) presents another highly effective non-invasive option, particularly for trigeminal neuralgia. Findings confirm that SRS provides significant pain relief with a favorable safety profile for many individuals with this debilitating condition [6].

The various factors influencing treatment success and recurrence rates are crucial for understanding its role in functional neurosurgical interventions.Focusing on Parkinson's disease tremor, unilateral focused ultrasound thalamotomy offers immediate and sustained improvement in tremor control. This minimally invasive procedure significantly enhances motor function and quality of life [7].

Its safety profile, characterized by transient side effects, makes it a suitable alternative for patients who cannot or prefer not to undergo DBS.Innovations in DBS programming are continually advancing therapeutic outcomes for movement disorders. Current clinical practices and emerging technologies, such as refined algorithms, adaptive stimulation, and closed-loop systems, are enhancing treatment efficacy [8].

The shift towards personalized and automated programming strategies aims to optimize symptom control while minimizing adverse effects, thereby improving patient experience and long-term effectiveness.Looking to the future, gene therapy represents a promising frontier for Parkinson's disease within functional neurosurgery. A systematic review and meta-analysis synthesizes evidence from clinical trials, demonstrating the potential of targeted gene delivery to improve motor symptoms by modulating specific neural pathways [9].

This approach offers a novel avenue for addressing the underlying pathology of the disease.Finally, the ethical and practical dimensions of DBS for psychiatric disorders are profoundly important. This involves careful consideration of informed consent, patient autonomy, and the potential for personality changes [10].

A rigorous ethical framework and a multidisciplinary approach are advocated to safeguard patient well-being and maintain the integrity of these advanced neurosurgical interventions.

Description

Deep Brain Stimulation (DBS) is a cornerstone of functional neurosurgery, offering profound benefits for various debilitating conditions. For Parkinson's disease, globus pallidus internus (GPi) DBS has shown remarkable long-term effectiveness, leading to sustained improvements in motor symptoms and an enhanced quality of life [1]. Achieving optimal results from GPi DBS necessitates meticulous patient selection and advanced surgical expertise. Similarly, the advancements in DBS programming, encompassing refined algorithms, adaptive stimulation, and closed-loop systems, are continuously optimizing therapeutic outcomes for movement disorders. This evolution points towards more personalized and automated strategies aimed at maximizing symptom control while concurrently minimizing side effects, significantly improving the patient experience and long-term efficacy [8]. Deep Brain Stimulation (DBS) continues to be a crucial therapeutic option across a range of neurological and psychiatric conditions.Beyond Parkinson's, DBS proves invaluable for other complex neurological and psychiatric conditions. Anterior Nucleus of Thalamus (ANT) DBS, through systematic review and meta-analysis, confirms a significant reduction in seizure frequency over time for individuals with drug-resistant epilepsy, providing a critical treatment alternative [2]. The safety profile is generally manageable, markedly improving quality of life for severe epilepsy cases. Moreover, DBS is a vital therapeutic option for severe, treatment-resistant obsessive-compulsive disorder (OCD). Studies meticulously examining individual patient data confirm substantial symptom reduction and improved functional outcomes for many patients, highlighting the sustained benefits and the importance of specialized care centers and careful patient selection [5]. Functional neurosurgery is continuously evolving, demonstrating remarkable efficacy in improving patient outcomes.Functional neurosurgery also embraces non-invasive and minimally invasive techniques. Focused ultrasound thalamotomy stands out as an effective non-invasive ablative treatment for essential tremor, providing immediate and significant tremor suppression that enhances motor function and quality of life [3]. Its safety profile, marked by transient side effects, makes it a valuable alternative to traditional surgical approaches. In a related application, unilateral focused ultrasound thalamotomy specifically addresses Parkinson's disease tremor. This minimally invasive procedure offers immediate and sustained improvement in tremor control, substantially enhancing motor function and quality of life, serving as a suitable alternative for patients who may not be candidates for DBS [7].For chronic pain management, spinal cord stimulation (SCS) presents substantial relief. A comprehensive systematic review and meta-analysis demonstrates that SCS effectively reduces chronic back and leg pain and improves functional status in patients unresponsive to conventional therapies [4]. The success of long-term pain management with SCS emphasizes the crucial role of patient selection and multidisciplinary care. In the realm of non-invasive pain interventions, stereotactic radiosurgery (SRS) is a highly effective option for treating trigeminal neuralgia. Findings confirm that SRS offers significant pain relief with a favorable safety profile, securing its role in the functional neurosurgical toolkit for this debilitating condition [6].The landscape of functional neurosurgery is continually expanding, with emerging therapies like gene therapy for Parkinson's disease showing significant promise. Systematic reviews are exploring this frontier, synthesizing evidence from clinical trials and demonstrating the potential of targeted gene delivery to improve motor symptoms by modulating specific neural pathways [9]. These advancements offer a glimpse into addressing the underlying pathology of Parkinson's. Alongside therapeutic progress, complex ethical and practical considerations are paramount, particularly concerning DBS for psychiatric disorders. Discussions focus on crucial aspects such as informed consent, patient autonomy, potential personality changes, and the stringent selection criteria for these vulnerable populations. A rigorous ethical framework and a multidisciplinary approach are essential to ensure patient well-being and uphold the integrity of these profound interventions [10].

Conclusion

Deep Brain Stimulation (DBS) continues to be a crucial therapeutic option across a range of neurological and psychiatric conditions. Studies highlight its sustained effectiveness in managing Parkinson's disease motor symptoms and improving quality of life, particularly with GPi DBS, emphasizing careful patient selection and expert technique. ANT DBS shows promise for drug-resistant epilepsy by significantly reducing seizure frequency and improving quality of life. For essential tremor and Parkinson's tremor, focused ultrasound thalamotomy offers immediate and sustained tremor suppression as a non-invasive or minimally invasive alternative, respectively, with manageable side effects. Spinal cord stimulation (SCS) provides substantial pain relief for chronic back and leg pain, with successful long-term outcomes dependent on patient selection and multidisciplinary care. DBS is also a critical option for severe, treatment-resistant obsessive-compulsive disorder, demonstrating significant symptom reduction and improved functional outcomes over long periods. Stereotactic radiosurgery (SRS) serves as an effective non-invasive treatment for trigeminal neuralgia, offering significant pain relief and a favorable safety profile. Advancements in DBS programming, including adaptive and closed-loop systems, are optimizing symptom control and minimizing side effects, moving towards personalized strategies. Emerging gene therapy for Parkinson's disease explores targeted gene delivery to improve motor symptoms and address underlying pathology. Finally, the ethical and practical considerations for DBS in psychiatric disorders are paramount, advocating for rigorous frameworks, informed consent, and multidisciplinary approaches for patient well-being.

Acknowledgement

None

Conflict of Interest

None

References

1. Chang Y, Jung H, Chang J. "Long-term follow-up of globus pallidus internus deep brain stimulation for Parkinson's disease".J Neurosurg 132 (2020):545-552.

Indexed at, Google Scholar, Crossref

2. Li Y, Chen X, Liang S. "Long-term efficacy and safety of anterior nucleus of thalamus deep brain stimulation for drug-resistant epilepsy: a systematic review and meta-analysis".J Clin Neurosci 99 (2022):121-127.

Indexed at, Google Scholar, Crossref

3. Shah A, Dykewicz C, Sair HI. "Focused Ultrasound Thalamotomy for Essential Tremor: A Systematic Review and Meta-Analysis".Mov Disord Clin Pract 7 (2020):508-515.

Indexed at, Google Scholar, Crossref

4. Al-Kaisy A, Parker J, Green C. "Spinal Cord Stimulation for Chronic Back and Leg Pain: A Systematic Review and Meta-Analysis".Pain Pract 20 (2020):161-177.

Indexed at, Google Scholar, Crossref

5. De DJ, Denys D, Figee M. "Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Individual Patient Data".Biol Psychiatry Cogn Neurosci Neuroimaging 5 (2020):1042-1050.

Indexed at, Google Scholar, Crossref

6. Tuleasca C, Faouzi M, Barragán-Campos HM. "Stereotactic Radiosurgery for Trigeminal Neuralgia: A Systematic Review and Meta-Analysis".J Neurosurg 133 (2020):491-503.

Indexed at, Google Scholar, Crossref

7. Sperling SA, Dykewicz C, Sair HI. "Unilateral Focused Ultrasound Thalamotomy for Parkinson's Disease Tremor: A Systematic Review and Meta-Analysis".Parkinsonism Relat Disord 74 (2020):81-87.

Indexed at, Google Scholar, Crossref

8. Horn A, Ostrem JL, de HC. "Advances in Deep Brain Stimulation Programming: Current and Future Perspectives".Prog Brain Res 253 (2020):231-252.

Indexed at, Google Scholar, Crossref

9. Pallett S, Gilbertson JA, Patel NK. "Gene therapy for Parkinson's disease: a systematic review and meta-analysis".J Neurol Neurosurg Psychiatry 90 (2019):444-453.

Indexed at, Google Scholar, Crossref

10. Schechtman RA, Kofman M, Drazin D. "Ethical and Practical Considerations in Deep Brain Stimulation for Psychiatric Disorders".J Neurol Sci 408 (2020):116560.

Indexed at, Google Scholar, Crossref